Clinical Updates – Page 32

Distinct Small Vessel Disease Phenotype Linked to Monoallelic NOTCH3 Loss-of-Function Variants: Differentiation from CADASIL and Clinical Implications

By MedXY 09/04/2025

Monoallelic NOTCH3 loss-of-function variants cause a subclinical small vessel disease distinct from CADASIL, with white matter changes but lower stroke risk; cardiovascular risk factors and aging exacerbate the phenotype.

Clinical Updates news OB/GYN & Women's Health Specialties

Estradiol Hormone Therapy Route Influences Memory Types in Postmenopausal Women

By MedXY 09/03/2025

Estradiol-based hormone therapy's impact on memory varies by administration route—with transdermal delivery linked to better episodic memory and oral delivery to improved prospective memory. Earlier menopause onset correlates with poorer cognitive performance.

Clinical Updates Dermatology news Nursing & care Pediatrics Specialties

Daily Emollient Use in Infants: A Promising Strategy to Prevent Pediatric Atopic Dermatitis

By MedXY 09/03/2025

A large pragmatic trial demonstrates that daily emollient application starting before 9 weeks of age significantly reduces the risk of atopic dermatitis by 24 months in infants not selected for high risk, offering a feasible preventive approach in pediatric dermatology.

Allergy & Immunology Clinical Updates Dermatology news Psychiatry Specialties

Elevated Risk of Depression and Anxiety in Hidradenitis Suppurativa: Implications Beyond Disease Severity

By MedXY 09/03/2025

Patients with hidradenitis suppurativa face a significantly increased risk of new-onset depression and anxiety, independent of disease severity, highlighting the need for universal psychiatric assessment in this population.

Allergy & Immunology Clinical Updates Dermatology news Orthopedics Specialties

Combination Targeted Therapy in Psoriatic Arthritis: Evaluating Infection Risks and Usage Patterns

By MedXY 09/03/2025

This article evaluates the prevalence and infection risks associated with combination targeted therapies in adults with psoriatic arthritis, revealing no significant increase in serious or opportunistic infections compared to standard therapy.

$Innovative All-Oral Therapy: Linperlisib Plus Chidamide Shows Promise in Relapsed or Refractory Cutaneous T-Cell Lymphoma$

Clinical Updates Hematology-Oncology news Specialties

Innovative All-Oral Therapy: Linperlisib Plus Chidamide Shows Promise in Relapsed or Refractory Cutaneous T-Cell Lymphoma

By MedXY 09/03/2025

A phase 1 trial of linperlisib combined with chidamide demonstrated manageable safety and notable efficacy in relapsed/refractory CTCL, offering a potential new oral treatment option for advanced disease, especially mycosis fungoides.

Allergy & Immunology Cardiology Clinical Updates Dermatology news Specialties

Interleukin-17 Inhibitors and Cardiovascular Risk: Evaluating Early Major Adverse Cardiovascular Events

By MedXY 09/03/2025

A national database study finds no significant increase in early major adverse cardiovascular events (MACEs) after starting IL-17 inhibitors in psoriasis and related diseases, although a modest risk cannot be excluded.

AI Clinical Updates Oncology Specialties Urology

AI Foundation Model Revolutionizes Non-Invasive Diagnosis and Grading of Prostate Cancer

By MedXY 09/03/2025

A multidisciplinary Chinese team has developed an AI-driven MRI-pathology foundation model that enables accurate, non-invasive diagnosis and grading of prostate cancer, significantly improving clinical decision-making and reducing unnecessary biopsies.

Cardiology Clinical Updates Public Health Specialties

PANDA II Trial Confirms Influenza Vaccination as Essential Intervention for Acute Heart Failure Patients

By MedXY 09/03/2025

The PANDA II study demonstrates that influenza vaccination significantly reduces mortality and rehospitalization in acute heart failure patients, supporting its inclusion as a standard component of heart failure management worldwide.

Cardiology Clinical Updates news Radiology Specialties

Myocardial T1 Mapping and Extracellular Volume: Emerging Prognostic Tools in Heart Failure and Non-Ischaemic Dilated Cardiomyopathy

By MedXY 09/03/2025

Cardiac MRI T1 mapping and extracellular volume fraction (ECV) provide noninvasive markers of myocardial fibrosis, showing consistent prognostic value across heart failure subtypes and non-ischaemic dilated cardiomyopathy for adverse cardiovascular outcomes.

Cardiology Clinical Updates news Specialties

Reevaluating Beta-Blocker Therapy Post-Myocardial Infarction with Preserved Ejection Fraction: Insights from Recent Trials and Meta-Analyses

By MedXY 09/02/2025

Recent evidence challenges the routine use of long-term beta-blockers after myocardial infarction in patients with preserved ejection fraction, highlighting comparable outcomes with or without therapy and raising safety and efficacy considerations in contemporary practice.

Cardiology Clinical Updates news Specialties

Decline in LVEF Predicts Ventricular Tachyarrhythmias and Mortality in HFpEF: Insights from the CHART-2 Study

By MedXY 09/02/2025

A mild-to-significant decline in left ventricular ejection fraction (LVEF) in heart failure with preserved ejection fraction (HFpEF) signals higher risks of lethal arrhythmias, sudden cardiac death, and mortality, underscoring the need for ongoing LVEF monitoring.

Cardiology Clinical Updates news Specialties

Volenrelaxin in HFpEF: Unexpected Worsening of Congestion Despite Improvements in Left Atrial Function

By MedXY 09/02/2025

This phase 2 trial shows that volenrelaxin, a long-acting relaxin analog, failed to improve overall congestion or kidney function in HFpEF patients and was linked to worsening congestion and safety signals, despite modest left atrial function improvement at low dose.

Cardiology Clinical Updates news Specialties

Low-Dose Digoxin Enhances Cardiac Function in Heart Failure with Preserved EF and Atrial Fibrillation: Insights from the RATE-AF Trial

By MedXY 09/02/2025

The RATE-AF trial demonstrates that low-dose digoxin significantly improves systolic function and symptoms in patients with heart failure, preserved ejection fraction, and permanent atrial fibrillation compared to beta-blockers, with fewer adverse events.

Cardiology Clinical Updates Gastroenterology Specialties

Routine Helicobacter pylori Screening Post-Myocardial Infarction: Insights from the HELP-MI SWEDEHEART Trial

By MedXY 09/02/2025

Routine H. pylori screening after acute myocardial infarction does not significantly reduce upper gastrointestinal bleeding incidence; targeted screening in anemia or kidney failure subgroups may offer benefit.

Cardiology Clinical Updates Gastroenterology news Specialties

Routine Helicobacter pylori Screening Post-Myocardial Infarction: Insights from the HELP-MI SWEDEHEART Trial

By MedXY 09/02/2025

In a large Swedish cluster-randomized trial, routine Helicobacter pylori screening after acute myocardial infarction did not significantly reduce upper gastrointestinal bleeding, though high-risk subgroups may benefit.

AI Clinical Updates news Specialties

Harnessing AI in Clinical Documentation: Evaluating Large Language Model-Generated Hospital Discharge Summaries

By MedXY 09/02/2025

A study comparing large language model-generated versus physician-generated discharge summaries found comparable quality and safety, suggesting AI-assisted documentation could reduce clinical burden without compromising patient care.

Clinical Updates news Nursing & care Orthopedics Specialties

Revolutionizing Osteoporosis Screening in High-Risk Older Men: The Impact of a Remote Bone Health Service

By MedXY 09/02/2025

A cluster randomized trial demonstrates a centralized remote bone health service significantly improves osteoporosis screening, treatment initiation, adherence, and bone density outcomes in high-risk older men compared to usual care.

Clinical Updates Diabetes & Endocrinology news Specialties

Triple Therapy Enhances Glycemic Control in Cystic Fibrosis Patients with Abnormal Glucose Tolerance

By MedXY 09/02/2025

Elexacaftor-tezacaftor-ivacaftor significantly improves glucose tolerance, lowers A1c and sweat chloride levels, and demonstrates safety in cystic fibrosis patients with impaired glucose tolerance or cystic fibrosis-related diabetes over 48 weeks.

Allergy & Immunology Clinical Updates Dermatology Gastroenterology

Alopecia Areata Linked to Elevated Risk of Microscopic Colitis and Other Immune-Mediated GI Disorders: Clinical Insights

By MedXY 09/01/2025

A large retrospective cohort study identifies a significant association between alopecia areata and increased risks of microscopic colitis, celiac disease, Crohn’s disease, eosinophilic esophagitis, and ulcerative colitis, highlighting the need for gastrointestinal screening in affected patients.